🇺🇸 FDA
Patent

US 10265382

Complexes of IL-15 and IL-15Ralpha and uses thereof

granted A61KA61K2039/5152A61K2039/5156

Quick answer

US patent 10265382 (Complexes of IL-15 and IL-15Ralpha and uses thereof) held by The United States of America, as represented by the Secretary, Department of Health and Human Services expires Mon Apr 18 2039 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The United States of America, as represented by the Secretary, Department of Health and Human Services
Grant date
Tue Apr 23 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Apr 18 2039 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
12
CPC classes
A61K, A61K2039/5152, A61K2039/5156, A61K2039/55527, A61K35/13